The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Alessa, Aquestive, Kezar, PDS, Uniqure.

Biopharma happenings, including deals and partnerships, and other news in brief: Acepodia, Anaptys, Avista, Biocytogen, Cytoreason, Dewpoint, GSK, Iktos, Link Cell Therapies, Madrigal, Medilink, Nona, Pfizer, Pierre, Roche, Sanofi, Tesaro.

Clinical updates, including data readouts and publications: Acousia, Clarametyx, Eli Lilly, Enyo, Innovent, Krystal, Krystal, Zyus.

Biopharmas raising money in public or private financings, including: Airnexis, Aurora, Clene, Enodia, Find, Ibio, Medipost, Monte Rosa, Orca, Ribo, Sonothera.

New hires and promotions in the biopharma industry, including: Ashvattha, Enhanced Genomics, GC, Octave, Praxis, Pulse, Ray, Septerna.

New hires and promotions in the med-tech industry, including: Dentsply Sirona, Hello Heart, Henry Schein, Renata Medical, Teleflex, SS Innovations.

Med-tech firms raising money in public or private financings, including: AI4Eyes, Major Medical Devices, Nanochon, Ventaris.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Attralus, Bayer, Boston Sci, Caris Life, Distalmotion, Everlywell, Haemonetics, Hydrix, Medicines360, Neuraxis, Orchestra Biomed, Syncardia, Valencia Technologies, Vivasure.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Medtronic, Neurolief, Oxford Nanopore.